CorMedix competitors

CorMedix's competitors include Innovation Pharmaceuticals, Alexion Pharmaceuticals, Syneos Health and Oncologie
Add company...
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Innovation Pharmaceuticals
Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Syneos Health
Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.
Oncologie
Oncologie is a biopharmaceutical company.
Founding Date
Founding Date
2006
Founding Date
2007
Founding Date
1992
Founding Date
2010
Founding Date
2018
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Bedminster Township, US HQ
Locations
Beverly, US HQ
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Toronto, CA
see more
Locations
Raleigh, US HQ
Locations
Boston, US HQ
Shanghai, CN
Employees
Employees
1456% increase
Employees
15
Employees
2,52519% decrease
Employees
6,800
Employees
4
Valuation ($)
Valuation ($)
26.2 m
Valuation ($)
103.4 m
Valuation ($)
26.7 b
Valuation ($)
4.9 b
Valuation ($)
N/A
Facebook likes
Facebook likes
793
Facebook likes
276
Facebook likes
N/A
Facebook likes
7.3 k
Facebook likes
N/A
Twitter followers
Twitter followers
620
Twitter followers
201
Twitter followers
1.8 k
Twitter followers
12.1 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$329.3k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$3.1b (FY, 2016)
Revenue (est.)
$1.6b (FY, 2016)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$115k (FY, 2017)
Cost of goods
N/A
Cost of goods
$258m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$214.4k (FY, 2017)
Gross profit
N/A
Gross profit
$2.8b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($33m) (FY, 2017)
Net income
($12.9m) (FY, 2016)
Net income
$399m (FY, 2016)
Net income
$112.6m (FY, 2016)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 11.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Innovation Pharmaceuticals
HQ
Beverly, US
Employees
15

Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.

View company
Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,525↓ 19% decrease

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company
Syneos Health
HQ
Raleigh, US
Employees
6,800

Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.

View company
Oncologie
HQ
Boston, US
Employees
4

Oncologie is a biopharmaceutical company.

View company